We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-11.48%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.63B
AUM Growth
-$644M
Cap. Flow
-$229M
Cap. Flow %
-8.7%
Top 10 Hldgs %
36.43%
Holding
110
New
23
Increased
22
Reduced
18
Closed
21

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$62.1M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$46.1M
3
CP icon
Canadian Pacific Kansas City
CP
+$45.9M
4
FIS icon
Fidelity National Information Services
FIS
+$44M
5
RPRX icon
Royalty Pharma
RPRX
+$43.2M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$147M
2
MSFT icon
Microsoft
MSFT
+$93.8M
3
SPGI icon
S&P Global
SPGI
+$84.8M
4
SCHW
Charles Schwab
SCHW
+$82.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$73.6M

Sector Composition

Rank Sector Weight
1 Healthcare 56.33%
2 Industrials 11.58%
3 Consumer Discretionary 10.43%
4 Technology 7.11%
5 Financials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEPG icon
51
PepGen
PEPG
$196M
$11.7M 0.45%
+1,181,428
New +$13.2M
CMRX
52
DELISTED
Chimerix, Inc.
CMRX
$11M 0.42%
5,271,696
+2,505,077
+91% +$8.05M
TMUS icon
53
T-Mobile US
TMUS
$190B
$10.5M 0.4%
+78,404
New +$10.2M
CVX icon
54
Chevron
CVX
$366B
$10.3M 0.39%
+71,154
New +$11.8M
MREO
55
Mereo BioPharma
MREO
$47.3M
$10.2M 0.39%
9,142,067
– –
OXY icon
56
Occidental Petroleum
OXY
$56B
$10.2M 0.39%
+172,642
New +$10.6M
COP icon
57
ConocoPhillips
COP
$141B
$9.95M 0.38%
+110,798
New +$11.4M
HRTX icon
58
Heron Therapeutics
HRTX
$90.7M
$9.07M 0.34%
3,251,048
+382,000
+13% +$1.53M
BHVN
59
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.98M 0.34%
61,631
– –
ALVO icon
60
Alvotech
ALVO
$1.28B
$8.21M 0.31%
+1,000,000
New +$9.31M
OTIC
61
DELISTED
Otonomy, Inc.
OTIC
$6.54M 0.25%
3,144,196
– –
ORIC icon
62
Oric Pharmaceuticals
ORIC
$1.39B
$5.66M 0.22%
1,262,464
+821,768
+186% +$3.28M
COGT icon
63
Cogent Biosciences
COGT
$7.22B
$5.41M 0.21%
+600,000
New +$4.1M
RACB
64
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$4.9M 0.19%
500,000
– –
IFRX icon
65
InflaRx
IFRX
$280M
$4.76M 0.18%
3,285,000
– –
BOLT icon
66
Bolt Biotherapeutics
BOLT
$7.78M
$4.55M 0.17%
111,513
– –
ATAI icon
67
AtaiBeckley Inc
ATAI
$2.68B
$4.42M 0.17%
+1,213,928
New +$4.96M
IRON icon
68
Disc Medicine
IRON
$3.02B
$4.01M 0.15%
79,076
– –
AMAM
69
DELISTED
Ambrx Biopharma Inc
AMAM
$3.95M 0.15%
1,491,832
– –
SLDB icon
70
Solid Biosciences
SLDB
$839M
$3.12M 0.12%
337,814
-143,843
-30% -$1.49M
TERN
71
DELISTED
Terns Pharmaceuticals
TERN
$3.07M 0.12%
1,238,800
– –
OMEG
72
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.96M 0.11%
300,000
– –
EBAC
73
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$2.94M 0.11%
300,000
– –
HRMY icon
74
Harmony Biosciences
HRMY
$2.26B
$2.86M 0.11%
+58,734
New +$2.64M
ROIV icon
75
Roivant Sciences
ROIV
$26.2B
$2.77M 0.11%
681,528
– –
1 2
3
4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Suvretta Capital Management held 110 positions worth $2.63B, down 20% from $3.27B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Suvretta Capital Management withdrew a net $229M in Q2 2022, closing 21 positions and reducing 18 holdings. Its most notable exit was Amazon, an estimated $147M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 47% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Suvretta Capital Management opened a new position in Block Inc worth $41.8M.

  • Suvretta Capital Management's largest Q2 2022 buy was Block Inc: 679,676 shares worth $41.8M.
  • Suvretta Capital Management added most to Royalty Pharma in Q2 2022, an estimated $43.2M increase.
  • Suvretta Capital Management's biggest Q2 2022 reduction was Microsoft, cutting an estimated $93.8M.
  • Suvretta Capital Management fully exited Amazon in Q2 2022, selling an estimated $147M.
  • Suvretta Capital Management's ten largest holdings make up 36% of its $2.63B portfolio in Q2 2022.
  • Suvretta Capital Management opened 23 new positions and closed 21 in Q2 2022.
  • Suvretta Capital Management's portfolio value fell 20% quarter-over-quarter to $2.63B.

Based on Suvretta Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.